Showing results (361-370 of 419) with videos related to
Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.Blood|September 26, 2000
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experienceM S Tallman, D Neuberg, J M Bennett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapseM S Tallman, D Hakimian, K J Kopecky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcomeA P Rapoport, J M Rowe, P A Kouides, et al.Journal of Cancer Research and Clinical Oncology|June 11, 1999
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromesW Verbeek, B Wörmann, P Koch, et al.Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.Clinical and Experimental Dermatology|October 4, 2018
Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skinJ S Lehman, S Dasari, S S Damodaran, et al.Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.Bone Marrow Transplantation|November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.The New England Journal of Medicine|October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemiaM S Tallman, J W Andersen, C A Schiffer, et al.Pageof 42